Who owns ENSYSCE BIOSCIENCES ORD?
- Ticker: ENSC
- CUSIP Number: 293602504
Tip: Access positions for across all investors
Analyze quarterly positions in Ensysce Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ensysce Biosciences Ord stock
Who bought or sold ENSYSCE BIOSCIENCES ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 150k | $138k | 100% | Dec 2025 |
|
| Perceptive Advisors | 87k | $47k | 0% | Mar 2026 |
|
| Geode Capital Management | 74k | $40k | 234% | Mar 2026 |
|
| Citadel Advisors | 57k | $31k | 100% | Mar 2026 |
|
| Vanguard Group | 37k | $34k | 0% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 24k | $13k | 100% | Mar 2026 |
|
| Jane Street | 14k | $7.3k | 100% | Mar 2026 |
|
| Tru Independence Asset Management 2 | 13k | $7.0k | 8% | Mar 2026 |
|
| Vanguard Capital Management | 13k | $6.9k | 100% | Mar 2026 |
|
| UBS Group | 8.8k | $4.7k | 8691% | Mar 2026 |
|
| Tower Research Capital | 5.3k | $4.9k | 295% | Dec 2025 |
|
| FNY Investment Advisers | 3.0k | $999.900000 | 0% | Mar 2026 |
|
| SBI Securities | 486.00 | $262.002600 | 15% | Mar 2026 |
|
| BlackRock | 65.00 | $35.002500 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 41.00 | $37.998800 | 100% | Dec 2025 |
|
Who sold out of Ensysce Biosciences Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 99k | $91k |
| Hrt Financial | Dec 2025 | 25k | $22k |
| Financial Plan | Dec 2025 | 24k | $22k |
| Two Sigma Securities | Dec 2025 | 22k | $20k |
| Williams & Novak | Dec 2025 | 18k | $16k |
| Renaissance Technologies | Sep 2025 | 16k | $37k |
| Virtu Financial | Sep 2025 | 14k | $34k |
| XTX Topco | Sep 2025 | 11k | $26k |